KDM1A and Alzheimer disease: In view of the link between AD and T2DM 77, 78, these results, clearly suggest that targeting either HMG20A or the LSD1-CoREST complex in astrocytes may improve neuroinflammation and glucose homeostasis while salvaging pancreatic islet function in T2DM patients 2.